Unique ID issued by UMIN | UMIN000017410 |
---|---|
Receipt number | R000020195 |
Scientific Title | Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent |
Date of disclosure of the study information | 2015/05/07 |
Last modified on | 2019/05/24 15:06:43 |
Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Japan |
Consecutive patients with coronary artery disease who were administered oral anticoagulant agent
Cardiology |
Others
NO
To evaluate the safety and efficacy of protocol for shortening the duration of dual antiplatelet therapy after second and third generation drug eluting stent implantation in patients who were administered oral anticoagulant agent.
Safety,Efficacy
Confirmatory
Pragmatic
Composite of major adverse events (death, acute coronary syndrome, stroke, any revascularization and systemic embolism), and hemorrhagic complication measured by BARC
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
One month duration of aspirin after drug eluting implantation in patients who were administered oral anticoagulant therapy
Conventional DAPT in patients who were not administered anticoagulant therapy
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients with coronary artery disease who were treated with second and third generation drug eluting stent
2. Patients with concomitant administration of oral anticoagulation agent
3. Patients over the age of 20
4. Patients who were obtained written informed consent
1. Patients who could not tolerate antiplatelet therapy or anticoagulation therapy
2. Patients who appeared to be inappropriate for this study, determined by the investigators
200
1st name | Naoto |
Middle name | |
Last name | Inoue |
Sendai Kousei Hospital
Cadiovascular Division
9800873
4-15, Hirose-cho, Sendai, Miyagi, Japan
+81-22-222-6181
inouena@est.hi-ho.ne.jp
1st name | Kazunori |
Middle name | |
Last name | Horie |
Sendai Kousei Hospital
Cardiovascular Division
9800873
4-15, Hirose-cho, Sendai, Miyagi, Japan
+81-22-222-6181
horihori1015@gmail.com
Sendai Kousei Hospital
None
Other
Sendai Kousei Hospital
4-15, Hirose, Aoba, Sendai, Miyagi, Japan
+81222226181
heartcenter@st.cat-v.ne.jp
NO
2015 | Year | 05 | Month | 07 | Day |
Unpublished
285
Main results already published
2015 | Year | 01 | Month | 01 | Day |
2015 | Year | 01 | Month | 21 | Day |
2015 | Year | 01 | Month | 10 | Day |
2018 | Year | 12 | Month | 31 | Day |
2015 | Year | 05 | Month | 03 | Day |
2019 | Year | 05 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020195
Research Plan | |
---|---|
Registered date | File name |
2018/12/04 | 抗凝固デザイン, DAPT + OAC.docx |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |
2019/05/06 | DAPT in AF, UMIN.xlsx |